MIAMI, Feb. 7 /PRNewswire/ -- The CyberKnife Centers of Miami, Palm Beach and Tampa have been invited to join M.D. Anderson in a sponsored study regarding the treatment of lung cancer patients through surgery vs. CyberKnife.
The study is being led by Jack Roth, MD, from the MD Anderson Cancer Center, who is the principle investigator and co-PI’s Ritsuko Komaki, MD, and Joe Chang, MD, PhD, from the MD Anderson Cancer Center and John Kresl, MD, PhD, from St. Joseph’s/BNI.
CyberKnife Executive Director, Dr. James G. Schwade, FACRO, FACR, FASTRO, says “we are excited and prepared to be a part of such an important study in the field of lung cancer treatment alternatives to surgery. The CyberKnife is extremely effective at treating lung cancer.”
CyberKnife manufacturer Accuray and M.D. Anderson are sponsoring the cancer study with oversight being managed by M.D. Anderson Cancer Center.
For more information on CyberKnife Centers of Miami, Palm Beach and Tampa, please visit www.morsecyberknife.com, or call 1-800- 204-0455.
CONTACT: Susan Nefzger of Susan Nefzger PR & Web Marketing,
+1-561-632-9525, susannefzger@comcast.net, for CyberKnife Centers
Web site: http://www.morsecyberknife.com/
